Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Anisodine Hydrobromide in Patients With Ischemic Stroke Undergoing Endovascular Treatment

NCT07513233 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07513233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07513233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Anisodine Hydrobromide in Patients With Ischemic Stroke Undergoing Endovascular Treatment
Lead sponsor
Capital Medical University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 28, 2026
Completion date
November 20, 2026
Enrollment
92 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke